Five numbers in the abstract
Where each one falls
Where it lands on the map
What it changes
Among 10 other studies
the abstract, start to end
… of cardiovascular (CV) death by 23% [HR 0.77, 95% CI (0.68, 0.88)], major adverse cardiovascular events (MACE) by 18% [HR 0.82, 95% CI (0.75, 0.90)], expanded MACE by 22% [HR 0.78, 95% CI (0.70, 0.85)], nonfatal myocardial infarction (MI) by 18% [HR 0.82, 95% CI (0.68, 0.92)], and …
← favours treatmentfavours comparator →
could be chanceAll-cause mortality
HR 0.770.68–0.88
Cardiovascular events
HR 0.680.56–0.83
Cardiovascular events
HR 0.820.68–0.92
Cardiovascular events
HR 0.820.75–0.90
Cardiovascular events
HR 0.780.70–0.85
GLP-1 receptor agonistsCardiovascular eventsAll-cause mortality
GLP-1 receptor agonists × cardiovascular eventshelps?mixed
unlikelylikely
0.50not counted
GLP-1 receptor agonists × all-cause mortalityhelps?replicated
unlikelylikely
0.88not counted
← favours treatmentfavours comparator →
1 / 5